CASI Pharmeceuticals

Analyst Coverage

CASI Pharmaceuticals, Inc. is followed by the analyst(s) listed below. This list is provided for information purposes only. Please note that any opinions, estimates or forecasts regarding CASI Pharmaceutical’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of CASI Pharmaceuticals or its management. Analysts may be contacted directly for copies of their reports.

HC Wainwright & Co. Swayampakula Ramakanth (RK), Ph.D. sramakanth@hcwco.com
Zacks Small Cap Research Grant Zeng, CFA gzeng@zacks.com

About Us

CASI is a U.S. based pharmaceutical company with a platform to develop and accelerate the launch of pharmaceutical products and innovative therapeutics in China, U.S., and throughout the world. We are a NASDAQ-listed company, with offices in Rockville, Maryland, and a wholly owned subsidiary in Beijing, China through which substantially all of our operations are conducted.

Learn More

Poster

Corporate Presentation - BIO CEO & Investor Conference

Download →

Poster

Annual Meeting Presentation

Download →

Poster

Clinical Safety and Efficacy of the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Previously Treated, Locally Advanced or Metastatic Triple-Negative Breast Cancer

Download →